Published in Blood on August 15, 1994
Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood (2005) 2.93
EVI1 induces myelodysplastic syndrome in mice. J Clin Invest (2004) 1.72
Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci U S A (1996) 1.65
The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO J (2000) 1.12
Molecular biology of myelodysplastic syndromes. Semin Oncol (2011) 1.01
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Blood (2012) 1.01
Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Br J Cancer (1996) 1.01
Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol (2009) 0.99
AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells. J Biol Chem (2008) 0.97
Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases. Stem Cells Transl Med (2014) 0.97
Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase. Cell Cycle (2012) 0.92
EVI1 promotes tumor growth via transcriptional repression of MS4A3. J Hematol Oncol (2015) 0.85
Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research. Blood (2015) 0.84
Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis. PLoS One (2011) 0.81
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they? Haematologica (2012) 0.80
Redundant roles of PRDM family members in zebrafish craniofacial development. Dev Dyn (2012) 0.78
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid. Cell Cycle (2014) 0.76
A closely linked genetic marker for cystic fibrosis. Nature (1985) 7.85
The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Public Health (1999) 4.84
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell (1999) 3.15
Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity (2000) 3.06
Genetic testing: a round table conversation. Part I. Intern Med J (2004) 2.96
A mapped set of genetic markers for human chromosome 9. Genomics (1988) 2.80
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Why the tobacco industry fears the passive smoking issue. Int J Health Serv (1990) 2.59
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell (2000) 2.41
Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32
SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell (1999) 2.19
Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest (1989) 2.18
Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med (1997) 2.15
Biogeographical patterns and determinants of invasion by forest pathogens in Europe. New Phytol (2012) 2.01
Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci U S A (1992) 1.90
Bereavement counselling after sudden infant death. Br Med J (Clin Res Ed) (1985) 1.79
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci U S A (1994) 1.78
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet Cytogenet (1999) 1.71
Genetic testing: a round table conversation. Part II. Intern Med J (2004) 1.71
Further linkage data on cystic fibrosis: the Utah Study. Am J Hum Genet (1986) 1.63
Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol (1992) 1.61
Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling. J Clin Endocrinol Metab (2003) 1.57
Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab (1995) 1.55
Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene (1990) 1.53
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood (1983) 1.43
Community perceptions about the tobacco industry and tobacco control funding. Aust N Z J Public Health (1999) 1.40
Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol (1990) 1.37
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2009) 1.26
Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep (1987) 1.25
Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res (1990) 1.24
Mammalian SH2-containing protein tyrosine phosphatases. Cell (1996) 1.24
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev (1998) 1.24
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro. J Natl Cancer Inst (1992) 1.23
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol (1997) 1.22
Signaling by the cytokine receptor superfamily. Ann N Y Acad Sci (1998) 1.22
Cytokines and growth factors signal through tyrosine phosphorylation of a family of related transcription factors. Immunity (1994) 1.17
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion. Oncogene (2012) 1.16
A molluscivorous Conus toxin: conserved frameworks in conotoxins. Biochemistry (1989) 1.15
The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene (1990) 1.15
Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet (1996) 1.15
Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol (1992) 1.15
Australian court decision on passive smoking upheld on appeal. BMJ (1993) 1.13
Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site. Nucleic Acids Res (1989) 1.13
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study. Leukemia (2002) 1.11
Construction of human genetic linkage maps: I. Progress and perspectives. Cold Spring Harb Symp Quant Biol (1986) 1.10
Numerical and structural chromosome aberrations in cultured lymphocytes and cutaneous fibroblasts of patients with multiple adenomas of the colorectum. Cancer (1982) 1.09
CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen. J Immunol (1991) 1.07
Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells. Int J Cancer (1983) 1.06
Legislation for smoking control in Western Australia. Br Med J (Clin Res Ed) (1985) 1.06
Emergency department observation wards. Med J Aust (2000) 1.06
Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood (1986) 1.05
Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. Blood (1997) 1.03
Core body temperature during menopausal hot flushes. Fertil Steril (1996) 1.02
A model for predicting growth responses in plants to changes in external water potential: Zea mays primary roots. J Theor Biol (1973) 1.02
Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet (1994) 1.01
Plasma cell tumors of the head and neck. J Otolaryngol (1988) 1.01
Protection from pathogenic SIV challenge using multigenic DNA vaccines. Immunol Lett (1999) 1.01
Temperamental contributions to the affect family of anxiety. Psychiatr Clin North Am (2001) 1.01
(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties. J Nat Prod (1996) 1.01
Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Br J Cancer (1996) 1.01
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant (2000) 1.00
Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood (1990) 0.99
Australian court rules that passive smoking causes lung cancer, asthma attacks, and respiratory disease. BMJ (1991) 0.99
The treatment of solitary plasmacytoma of bone and extramedullary plasmacytoma. Am J Clin Oncol (1987) 0.98
Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells. Blood (1988) 0.97
Extratesticular lesions: a radiological and pathological correlation. Australas Radiol (1994) 0.97
Preclinical evaluation of illudins as anticancer agents. Cancer Res (1987) 0.96
Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria. Leukemia (2010) 0.96
Telomerase activation in cervical cancer. Am J Pathol (1997) 0.96
Effects of publicity and a warning letter on illegal cigarette sales to minors. Aust J Public Health (1994) 0.96
T-cell subsets and suppressor cells in human bone marrow. Blood (1992) 0.95
Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity. J Virol (1992) 0.95
Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J Neurochem (2000) 0.95
A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. Virology (1998) 0.95
Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity. Cancer Res (1981) 0.95
Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicity. J Natl Cancer Inst (1990) 0.95
Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibody. Blood (1979) 0.94
Graph models of oncogenesis with an application to melanoma. J Theor Biol (2001) 0.94
Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood (1990) 0.94
Rubella vaccination: persistence of antibodies for 10-21 years. Lancet (1988) 0.94
Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes. Leukemia (2003) 0.93
Genes and gene products involved in growth regulation of tumor cells. Recent Results Cancer Res (1985) 0.93
Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol (1999) 0.93
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody. J Clin Invest (1985) 0.93
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia. Leukemia (2008) 0.92
Cognitive deficits in iron-deficient and iron-deficient anemic children. J Pediatr (1986) 0.92
Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia (2012) 0.92
Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis. Genes Chromosomes Cancer (2000) 0.91
Effect of interferon on colony formation in culture by blast cell progenitors in acute myeloblastic leukemia. Blood (1980) 0.91
Fourier transform-infrared spectroscopy as a new method for evaluating host resistance in the Dutch elm disease complex. Tree Physiol (2005) 0.91
Coronary sinus pacing clinical follow-up. Circulation (1978) 0.91
Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genet Cytogenet (1997) 0.90